These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8731161)

  • 21. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine.
    Dietz DM; Tapocik J; Gaval-Cruz M; Kabbaj M
    Physiol Behav; 2005 Oct; 86(3):347-55. PubMed ID: 16126238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cocaine, nicotine, dizocipline and alcohol on mice locomotor activity: cocaine-alcohol cross-sensitization involves upregulation of striatal dopamine transporter binding sites.
    Itzhak Y; Martin JL
    Brain Res; 1999 Feb; 818(2):204-11. PubMed ID: 10082805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated intracerebroventricular forskolin administration enhances behavioral sensitization to cocaine.
    Schroeder JA; Hummel M; Unterwald EM
    Behav Brain Res; 2004 Aug; 153(1):255-60. PubMed ID: 15219727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics.
    Drouin C; Blanc G; Villégier AS; Glowinski J; Tassin JP
    Synapse; 2002 Jan; 43(1):51-61. PubMed ID: 11746733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Individual differences in cocaine-induced locomotor sensitization in low and high cocaine locomotor-responding rats are associated with differential inhibition of dopamine clearance in nucleus accumbens.
    Sabeti J; Gerhardt GA; Zahniser NR
    J Pharmacol Exp Ther; 2003 Apr; 305(1):180-90. PubMed ID: 12649367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat.
    Ford AP; Marsden CA
    Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity.
    Hertel P; Byskov L; Didriksen M; Arnt J
    Eur J Pharmacol; 2001 Jun; 422(1-3):77-81. PubMed ID: 11430916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different locomotor sensitization responses to repeated cocaine injections are associated with differential phosphorylation of GluA1 in the dorsomedial striatum of adult rats.
    Kim M; Kim W; Baik JH; Yoon BJ
    Behav Brain Res; 2013 Nov; 257():71-6. PubMed ID: 24079996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice.
    Betancur C; Lépée-Lorgeoux I; Cazillis M; Accili D; Fuchs S; Rostène W
    Neuropsychopharmacology; 2001 Feb; 24(2):170-82. PubMed ID: 11120399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Centrally administered neurotensin suppresses locomotor hyperactivity induced by d-amphetamine but not by scopolamine or caffeine.
    Skoog KM; Cain ST; Nemeroff CB
    Neuropharmacology; 1986 Jul; 25(7):777-82. PubMed ID: 3748325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Motor hypoactivity induced by neurotensin and related peptides in mice.
    Meisenberg G; Simmons WH
    Pharmacol Biochem Behav; 1985 Feb; 22(2):189-93. PubMed ID: 3983212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preexposure to, but not cotreatment with, the neurotensin antagonist SR 48692 delays the development of cocaine sensitization.
    Horger BA; Taylor JR; Elsworth JD; Roth RH
    Neuropsychopharmacology; 1994 Nov; 11(3):215-22. PubMed ID: 7865101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of dopamine and norepinephrine reuptake produces additive effects on energy balance in lean and obese mice.
    Billes SK; Cowley MA
    Neuropsychopharmacology; 2007 Apr; 32(4):822-34. PubMed ID: 16841072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.
    Chou S; Davis C; Jones S; Li M
    Pharmacol Biochem Behav; 2015 Jan; 128():78-88. PubMed ID: 25433325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prior, repeated exposure to cocaine potentiates locomotor responsivity to central injections of corticotropin-releasing factor (CRF) in rats.
    Erb S; Funk D; Lê AD
    Psychopharmacology (Berl); 2003 Dec; 170(4):383-9. PubMed ID: 12955298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated neurotensin administration in the ventral tegmental area: effects on baseline and D-amphetamine-induced locomotor activity.
    Elliott PJ; Nemeroff CB
    Neurosci Lett; 1986 Jul; 68(2):239-44. PubMed ID: 3748452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, D-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice.
    Mcgeehan AJ; Janak PH; Olive MF
    Psychopharmacology (Berl); 2004 Jul; 174(2):266-73. PubMed ID: 14726993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine.
    Betancur C; Cabrera R; de Kloet ER; Pélaprat D; Rostène W
    Neuropsychopharmacology; 1998 Oct; 19(4):322-32. PubMed ID: 9718595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral effects of neurotensin in the open field: structure-activity studies.
    Elliott PJ; Chan J; Parker YM; Nemeroff CB
    Brain Res; 1986 Sep; 381(2):259-65. PubMed ID: 3756503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.